Immatics N.V - Warrants (01/07/2025) Return on Equity

Immatics N.V - Warrants (01/07/2025) (IMTXW) currently reports a ROE of -45.5%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Immatics N.V - Warrants (01/07/2025)'s ROE history and peer comparisons.

Immatics N.V - Warrants (01/07/2025)'s ROE of -45.5% is lower than the Healthcare sector average of 29.33%. That is roughly 255.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Immatics N.V - Warrants (01/07/2025)'s current -45.5% should be judged against Healthcare norms (sector average: 29.33%) and against IMTXW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -45.5%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Immatics N.V - Warrants (01/07/2025), and consider following IMTXW for alerts when major investors trade the stock.

Immatics N.V - Warrants (01/07/2025) is classified in the Healthcare sector. On ROE, it currently shows -45.5% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMTXW with unrelated industries.